Medical Education
Interview: Howard Marks
The interview with Howard Marks offers a personal and historical perspective on cannabis use, its cultural significance, and the impact it has had on individuals and communities. While the interview is primarily a...
The interview with Howard Marks offers a personal and historical perspective on cannabis use, its cultural significance, and the impact it has had on individuals and communities. While the interview is primarily a narrative of personal experience, it also highlights broader themes such as the legal, social, and health implications of cannabis use. This article provides a factual overview of the key points from the interview, supported by current medical and public health evidence, to help patients and carers understand the context and implications of cannabis use in the UK today.
Key takeaways
- Cannabis has been used for recreational and social purposes for decades, with historical and cultural significance in various parts of the world.
- The legal status of cannabis in the UK remains restrictive, with limited access for medical use and strict enforcement of anti-drug laws.
- Personal experiences with cannabis can vary widely, with some individuals reporting benefits such as relaxation and mood improvement, while others may experience adverse effects.
- Public health guidance in the UK focuses on reducing harm and promoting safer use, particularly among young people and those at risk of dependency.
Evidence base
The use of cannabis in the UK is primarily regulated under the Misuse of Drugs Act 1971, which classifies cannabis as a Class B drug. This legal framework has led to a focus on prevention and harm reduction rather than therapeutic use. While some research suggests that cannabis may have potential therapeutic applications for conditions such as chronic pain, epilepsy, and multiple sclerosis, the evidence is not yet robust enough to support widespread medical use.
The National Institute for Health and Care Excellence (NICE) has not issued guidelines recommending cannabis for medical use in the UK due to insufficient evidence of long-term safety and efficacy. Public health guidance from the UK government and health authorities emphasizes the risks associated with cannabis use, particularly for adolescents and young adults.
The Office for National Statistics reports that cannabis use is most common among individuals aged 16–24, with significant rates of regular use and associated health risks such as mental health issues, respiratory problems, and impaired cognitive function. The Medicines and Healthcare products Regulatory Agency (MHRA) advises that cannabis products should be used only under the supervision of a healthcare professional, and that the risks of use, including dependency and mental health effects, should be carefully considered.
Despite the legal and regulatory restrictions, there is growing interest in the potential for cannabis to be used for medical purposes. Some studies suggest that cannabis may help alleviate symptoms in certain conditions, but the evidence is limited and often conflicting. The UK government has not yet approved cannabis-based medicines for widespread use, and the availability of such products is restricted to a small number of licensed medicinal cannabis products. The evidence base for the medical use of cannabis remains limited, with many studies being of low quality or based on small sample sizes.
What patients should know
Cannabis use carries a range of potential risks and benefits that should be carefully considered. For patients, it is important to understand that while some individuals may find cannabis helpful for managing symptoms such as chronic pain or anxiety, the evidence for its effectiveness in these contexts is not yet conclusive. The UK's current regulatory framework does not support the use of cannabis for medical purposes, and access to cannabis-based medicines is limited.
Patients should be aware that the legal status of cannabis in the UK means that possession and use can result in criminal charges, even for medical use. For those considering cannabis use, it is essential to be aware of the potential health risks, including the risk of dependency, mental health issues, and respiratory problems. The UK government and health authorities recommend that individuals who are considering using cannabis for any purpose should consult with a healthcare professional to discuss the potential risks and benefits.
Patients should also be aware that the long-term effects of cannabis use are not fully understood, and that research in this area is ongoing. Patients should also be aware of the social and legal implications of cannabis use. In the UK, cannabis is classified as a controlled substance, and its use is illegal without a prescription. This means that individuals who use cannabis may face legal consequences, including fines or imprisonment. Patients should also be aware that the use of cannabis may affect their ability to drive or work, and that there are legal restrictions on driving under the influence of cannabis.
When to speak to a clinician
Patients should consider speaking to a clinician if they are experiencing symptoms that may be related to cannabis use, such as anxiety, depression, or changes in mood. It is also important to speak to a clinician if they are concerned about the potential risks of cannabis use, particularly if they are a young person or have a history of mental health issues. Patients should also seek medical advice if they are considering using cannabis for medical purposes, as the evidence for its effectiveness is limited and the risks are not fully understood.
Red flags that may indicate the need for a clinician's advice include persistent or worsening symptoms, difficulty in stopping cannabis use, or concerns about the impact of cannabis on daily life. Patients should also seek medical advice if they are experiencing physical symptoms such as respiratory issues, or if they are concerned about the legal implications of cannabis use. It is important to note that the UK's current regulatory framework does not support the use of cannabis for medical purposes, and patients should be aware of the legal and health risks associated with its use.
Questions to ask a clinician
- What are the potential risks and benefits of cannabis use for my specific condition?
- Are there alternative treatments that may be more effective or safer than cannabis?
- How can I use cannabis safely, if at all, to manage my symptoms?
- What are the legal implications of cannabis use in the UK, and how might this affect my life?
Source trail
- National Institute for Health and Care Excellence (NICE) guidelines on cannabis use
- Office for National Statistics reports on cannabis use in the UK
- Medicines and Healthcare products Regulatory Agency (MHRA) guidance